S&P 500   3,128.21 (-3.03%)
DOW   27,081.36 (-3.15%)
QQQ   215.37 (-2.72%)
AAPL   288.08 (-3.39%)
FB   196.77 (-1.97%)
MSFT   168.07 (-1.65%)
GOOGL   1,386.32 (-2.36%)
AMZN   1,972.74 (-1.82%)
CGC   19.62 (-3.35%)
NVDA   262.05 (-4.11%)
BABA   205.61 (-0.27%)
MU   52.10 (-5.29%)
GE   11.32 (-4.55%)
TSLA   799.91 (-4.06%)
AMD   47.57 (-3.16%)
T   37.35 (-1.84%)
ACB   1.51 (-2.58%)
F   7.23 (-4.49%)
NFLX   360.09 (-2.34%)
PRI   121.42 (-4.37%)
BAC   31.08 (-5.04%)
DIS   128.19 (-3.62%)
GILD   70.10 (-3.84%)
S&P 500   3,128.21 (-3.03%)
DOW   27,081.36 (-3.15%)
QQQ   215.37 (-2.72%)
AAPL   288.08 (-3.39%)
FB   196.77 (-1.97%)
MSFT   168.07 (-1.65%)
GOOGL   1,386.32 (-2.36%)
AMZN   1,972.74 (-1.82%)
CGC   19.62 (-3.35%)
NVDA   262.05 (-4.11%)
BABA   205.61 (-0.27%)
MU   52.10 (-5.29%)
GE   11.32 (-4.55%)
TSLA   799.91 (-4.06%)
AMD   47.57 (-3.16%)
T   37.35 (-1.84%)
ACB   1.51 (-2.58%)
F   7.23 (-4.49%)
NFLX   360.09 (-2.34%)
PRI   121.42 (-4.37%)
BAC   31.08 (-5.04%)
DIS   128.19 (-3.62%)
GILD   70.10 (-3.84%)
S&P 500   3,128.21 (-3.03%)
DOW   27,081.36 (-3.15%)
QQQ   215.37 (-2.72%)
AAPL   288.08 (-3.39%)
FB   196.77 (-1.97%)
MSFT   168.07 (-1.65%)
GOOGL   1,386.32 (-2.36%)
AMZN   1,972.74 (-1.82%)
CGC   19.62 (-3.35%)
NVDA   262.05 (-4.11%)
BABA   205.61 (-0.27%)
MU   52.10 (-5.29%)
GE   11.32 (-4.55%)
TSLA   799.91 (-4.06%)
AMD   47.57 (-3.16%)
T   37.35 (-1.84%)
ACB   1.51 (-2.58%)
F   7.23 (-4.49%)
NFLX   360.09 (-2.34%)
PRI   121.42 (-4.37%)
BAC   31.08 (-5.04%)
DIS   128.19 (-3.62%)
GILD   70.10 (-3.84%)
S&P 500   3,128.21 (-3.03%)
DOW   27,081.36 (-3.15%)
QQQ   215.37 (-2.72%)
AAPL   288.08 (-3.39%)
FB   196.77 (-1.97%)
MSFT   168.07 (-1.65%)
GOOGL   1,386.32 (-2.36%)
AMZN   1,972.74 (-1.82%)
CGC   19.62 (-3.35%)
NVDA   262.05 (-4.11%)
BABA   205.61 (-0.27%)
MU   52.10 (-5.29%)
GE   11.32 (-4.55%)
TSLA   799.91 (-4.06%)
AMD   47.57 (-3.16%)
T   37.35 (-1.84%)
ACB   1.51 (-2.58%)
F   7.23 (-4.49%)
NFLX   360.09 (-2.34%)
PRI   121.42 (-4.37%)
BAC   31.08 (-5.04%)
DIS   128.19 (-3.62%)
GILD   70.10 (-3.84%)
Log in

NASDAQ:RCM - R1 RCM Stock Price, Forecast & News

$13.08
-0.31 (-2.31 %)
(As of 02/25/2020 04:00 PM ET)
Today's Range
$12.90
Now: $13.09
$13.54
50-Day Range
$12.49
MA: $13.18
$13.91
52-Week Range
$8.77
Now: $13.09
$13.99
Volume1.19 million shs
Average Volume960,162 shs
Market Capitalization$1.50 billion
P/E RatioN/A
Dividend YieldN/A
Beta0.05
R1 RCM Inc provides revenue cycle management (RCM) for healthcare providers in the United States. It offers end-to-end RCM services to manage their revenue cycle operations, which encompass patient registration, insurance and benefit verification, medical treatment documentation and coding, and bill preparation and collection from patients and payers. Read More…

Industry, Sector and Symbol

Industry Management services
Sub-IndustryHealth Care Services
SectorFinance
Current SymbolNASDAQ:RCM
CUSIP00438V10
Phone312-324-7820

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$1.19 billion
Cash Flow$0.58 per share
Book Value$0.16 per share

Profitability

Net Income$12 million

Miscellaneous

Employees18,600
Market Cap$1.50 billion
Next Earnings Date5/14/2020 (Estimated)
OptionableNot Optionable

Receive RCM News and Ratings via Email

Sign-up to receive the latest news and ratings for RCM and its competitors with MarketBeat's FREE daily newsletter.


R1 RCM (NASDAQ:RCM) Frequently Asked Questions

What is R1 RCM's stock symbol?

R1 RCM trades on the NASDAQ under the ticker symbol "RCM."

How were R1 RCM's earnings last quarter?

R1 RCM Inc (NASDAQ:RCM) posted its earnings results on Thursday, February, 20th. The healthcare provider reported $0.01 EPS for the quarter, missing the consensus estimate of $0.04 by $0.03. The healthcare provider earned $314 million during the quarter, compared to analyst estimates of $318.36 million. R1 RCM had a net margin of 1.01% and a return on equity of 116.79%. The firm's revenue was up 19.4% compared to the same quarter last year. During the same quarter in the prior year, the business earned ($0.10) earnings per share. View R1 RCM's Earnings History.

When is R1 RCM's next earnings date?

R1 RCM is scheduled to release their next quarterly earnings announcement on Thursday, May 14th 2020. View Earnings Estimates for R1 RCM.

What guidance has R1 RCM issued on next quarter's earnings?

R1 RCM updated its FY 2020 Pre-Market earnings guidance on Thursday, February, 20th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $1.3-1.4 billion, compared to the consensus revenue estimate of $1.36 billion.

What price target have analysts set for RCM?

4 analysts have issued twelve-month price targets for R1 RCM's stock. Their forecasts range from $14.00 to $17.00. On average, they anticipate R1 RCM's stock price to reach $15.25 in the next year. This suggests a possible upside of 16.5% from the stock's current price. View Analyst Price Targets for R1 RCM.

What is the consensus analysts' recommendation for R1 RCM?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for R1 RCM in the last year. There are currently 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for R1 RCM.

Has R1 RCM been receiving favorable news coverage?

News articles about RCM stock have been trending very negative on Tuesday, InfoTrie Sentiment Analysis reports. The research firm identifies negative and positive media coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. R1 RCM earned a daily sentiment score of -3.0 on InfoTrie's scale. They also gave news stories about the healthcare provider a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the company's share price in the next few days. View News Stories for R1 RCM.

Are investors shorting R1 RCM?

R1 RCM saw a increase in short interest in the month of January. As of January 15th, there was short interest totalling 7,780,000 shares, an increase of 17.3% from the December 31st total of 6,630,000 shares. Based on an average daily trading volume, of 1,160,000 shares, the short-interest ratio is currently 6.7 days. Currently, 8.0% of the company's shares are sold short. View R1 RCM's Current Options Chain.

Who are some of R1 RCM's key competitors?

What other stocks do shareholders of R1 RCM own?

Based on aggregate information from My MarketBeat watchlists, some companies that other R1 RCM investors own include Alibaba Group (BABA), NVIDIA (NVDA), Baozun (BZUN), Marvell Technology Group (MRVL), Baidu (BIDU), JD.Com (JD), Canopy Growth (CGC), Model N (MODN), Advanced Micro Devices (AMD) and BioDelivery Sciences International (BDSI).

Who are R1 RCM's key executives?

R1 RCM's management team includes the folowing people:
  • Mr. Joseph Gerard Flanagan, Pres, CEO & Director (Age 48)
  • Mr. Gary S. Long, Exec. VP & Chief Commercial Officer (Age 49)
  • Mr. Richard B. Evans Jr., Sr. VP, Interim CFO, Corp. Controller & Chief Accounting Officer (Age 51)
  • Mr. Atif A. Rahim, Sr. VP of Investor Relations & Bus. Devel.
  • Mr. Corey Perman, Exec. VP of Compliance & Risk

Who are R1 RCM's major shareholders?

R1 RCM's stock is owned by many different of institutional and retail investors. Top institutional shareholders include FMR LLC (2.27%), State Street Corp (2.00%), Bank of New York Mellon Corp (1.92%), Geode Capital Management LLC (1.24%), Royce & Associates LP (1.15%) and Eaton Vance Management (1.14%). Company insiders that own R1 RCM stock include Albert Rene Zimmerli and Charles J Ditkoff. View Institutional Ownership Trends for R1 RCM.

Which major investors are selling R1 RCM stock?

RCM stock was sold by a variety of institutional investors in the last quarter, including Man Group plc, Renaissance Technologies LLC, Penn Capital Management Co. Inc., Falcon Point Capital LLC, Point72 Asset Management L.P., Castleark Management LLC, PNC Financial Services Group Inc. and Prudential Financial Inc.. View Insider Buying and Selling for R1 RCM.

Which major investors are buying R1 RCM stock?

RCM stock was purchased by a variety of institutional investors in the last quarter, including FMR LLC, Mckinley Capital Management LLC Delaware, Eaton Vance Management, Eagle Asset Management Inc., Tealwood Asset Management Inc., Parkman Healthcare Partners LLC, Bank of Montreal Can and Sectoral Asset Management Inc. View Insider Buying and Selling for R1 RCM.

How do I buy shares of R1 RCM?

Shares of RCM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is R1 RCM's stock price today?

One share of RCM stock can currently be purchased for approximately $13.09.

How big of a company is R1 RCM?

R1 RCM has a market capitalization of $1.50 billion and generates $1.19 billion in revenue each year. R1 RCM employs 18,600 workers across the globe.View Additional Information About R1 RCM.

What is R1 RCM's official website?

The official website for R1 RCM is http://www.r1rcm.com/.

How can I contact R1 RCM?

R1 RCM's mailing address is 401 NORTH MICHIGAN AVENUE SUITE 2700, CHICAGO IL, 60611. The healthcare provider can be reached via phone at 312-324-7820 or via email at [email protected]


MarketBeat Community Rating for R1 RCM (NASDAQ RCM)

Community Ranking:  2.1 out of 5 (star star)
Outperform Votes:  208 (Vote Outperform)
Underperform Votes:  297 (Vote Underperform)
Total Votes:  505
MarketBeat's community ratings are surveys of what our community members think about R1 RCM and other stocks. Vote "Outperform" if you believe RCM will outperform the S&P 500 over the long term. Vote "Underperform" if you believe RCM will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/25/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel